Sogeti Ireland Launches Life Science Practice
How Sogeti Ireland aims to be part of the industry ‘health fix’
In today’s new world, our health has become our priority. Indeed, the adage ‘your health is your wealth’ has never been so relevant. We all expect the healthcare and life sciences sectors to deliver on that priority. But they can’t do it alone. How can technology organizations like Sogeti Ireland be part of the transformation needed to make this happen?
Collaboration in the health value chain
A recent study by the Capgemini Research Institute reveals that consumers are increasingly demanding digital health and low-touch healthcare options. Described in the Institute’s research note ‘The health fix’ as a wake-up call, the current global pandemic offers myriad opportunities for life sciences companies and healthcare providers to improve health outcomes, enhance the patient experience, and reduce the cost of healthcare.
But, as ’The health fix’ report points out, this can only be achieved if life sciences companies, patients, doctors, regulators, payers, and technology firms collaborate.
Sogeti Ireland, part of the Capgemini Group, collaborates with players across the Republic of Ireland’s healthcare and life sciences ecosystem, and leverages Capgemini’s decades of experience, services and expertise in this industry.
According to Xavier de Bustos, head of Sogeti Ireland’s new, dedicated Life Sciences practice: “This is an important sector for the Irish economy and employment, as well as for the world post COVID-19 as organizations face many challenges in areas such as digitalization, regulation and compliance, supply chain, and R&D.”
In establishing a dedicated Life Sciences practice, Sogeti Ireland has brought together the best of what Capgemini and Altran its, recently acquired, engineering and R&D business can offer in support of this collaborative ecosystem. From patient centric products and treatments, IT healthcare, such as digital therapeutics, connected healthcare to software as a medical device (SAMD). That’s not all. The new practice brings strength in supporting the industry’s digital transformation with manufacturing execution system software, smart factories digital twin, AR/VR, and predictive analytics. It will also focus on regulatory and compliance areas: GxP, CSV, validations, etc, including the new Medical Device Regulations (MDR) and In-Vitro Diagnostic Regulations (IVDR).
These are all components of a connected, collaborative ecosystem. One that, according to ‘The health fix’ needs life sciences and healthcare companies to partner with technology companies, start-ups, and academia to fill gaps in talent and capabilities required for digital health. The research note adds that life sciences companies could leverage technology to provide patient support through mobile apps. For example, next-generation healthcare apps with personalized content can empower patients.
The report also states that the pandemic has “accelerated innovations in healthcare: connected devices, digital health solutions, fitness and wellness apps, and mental health programs”. It adds that, “a developing ecosystem of accelerating digital health technologies, growing acceptance of virtual or low-touch health services, as well as easing of regulations and a renewed focus on patient empowerment open new opportunities for life sciences companies and healthcare providers.”
For Sogeti Ireland, there is now a great opportunity to be part of this rapidly transforming industry. According to its Country Head James Govan, the dedicated Life Sciences practice has the potential to create more than 50 jobs in Ireland over the next two years as it offers increasingly sophisticated ‘Intelligent Industry’ solutions, technologies and processes.
To learn more about Sogeti Ireland’s dedicated Life Sciences practice, contact Xavier de Bustos here - email@example.com
- Xavier de BustosDirector Life Sciences Practice
+353 87 052 3956
Xavier de BustosDirector Life Sciences Practice
+353 87 052 3956